Lack of correlation between bcg-induced tuberculin skin test sensitisation and protective immunity in cattle

Vaccine

Volumn 29, Issue 33, 2011, Pages 5453-5458

  Whelan, A O ^a   Coad, M ^a   Upadhyay, B L ^a   Clifford, D J ^a   Hewinson, R G ^a   Vordermeier, H M ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

BCG; Bovine tuberculosis; DIVA; Skin test; Tuberculin; Vaccination

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BCG VACCINATION; BOVINE TUBERCULOSIS; CATTLE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; SKIN SENSITIZATION; TUBERCULIN TEST; VACCINATION;

ANIMALS; BCG VACCINE; CATTLE; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; TUBERCULIN TEST; TUBERCULOSIS, BOVINE;

EID: 79960345377     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.05.057     Document Type: Article

References (37)

1. Koch R. Weitere Mitteilungen uber ein Heilmittel gegen tuberculose. Dtsch Med Wochenschr 1890, 16:1029-1032.
2. Snider D.E. The tuberculin skin test. Am Rev Respir Dis 1982, 125(3 Pt 2):108-118.
3. Thoen C.O., Steele J.H. Mycobacterium bovis infection in animals and humans 1995, Iowa State University Press, Ames.
4. Buddle B.M. Vaccination of cattle against Mycobacterium bovis. Tuberculosis (Edinb) 2001, 81(1-2):125-132.
5. Hope J.C., Vordermeier H.M. Vaccines for bovine tuberculosis: current views and future prospects. Expert Rev Vaccines 2005, 4(6):891-903.
6. Krebs J.R. Bovine tuberculosis in cattle and badgers 1997, HMSO, p. 1-191.
7. Buddle B.M., Keen D., Thomson A., Jowett G., McCarthy A.R., Heslop J., et al. Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae. Res Vet Sci 1995, 59(1):10-16.
8. Skinner M.A., Buddle B.M., Wedlock D.N., Keen D., de Lisle G.W., Tascon R.E., et al. A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis. Infect Immun 2003, 71(9):4901-4907.
9. Vordermeier H.M., Chambers M.A., Cockle P.J., Whelan A.O., Simmons J., Hewinson R.G.R.G. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun 2002, 70(6):3026-3032.
10. Berggren S.A. Field experiment with BCG vaccine in Malawi. Br Vet J 1981, 137:88-94.
11. Waddington F.G., Ellwood D.C. An experiment to challenge the resistance to tuberculosis in B.C.G. vaccinated cattle in Malawi. Br Vet J 1972, 128(11):541-552.
12. Lalvani A., Pareek M. A 100 year update on diagnosis of tuberculosis infection. Br Med Bull 2010, 93:69-84.
13. Pollock J.M., Buddle B.M., Andersen P. Towards more accurate diagnosis of bovine tuberculosis using defined antigens. Tuberculosis (Edinb) 2001, 81(1-2):65-69.
14. Vordermeier H.M., Whelan A., Cockle P.J., Farrant L., Palmer N., Hewinson R.G. Use of synthetic peptides derived from the antigens esat-6 and cfp-10 for differential diagnosis of bovine tuberculosis in cattle. Clin Diagn Lab Immunol 2001, 8(3):571-578.
15. Whelan A.O., Clifford D., Upadhyay B., Breadon E.L., McNair J., Hewinson R.G., et al. Development of a skin test for bovine tuberculosis for differentiating infected from vaccinated animals. J Clin Microbiol 2010, 48(9):3176-3181.
16. Moodie P.A. Tuberculin reactions in BCG-vaccinated cattle. Br Vet J 1977, 133:642-645.
17. Coad M., Clifford D., Rhodes S.G., Hewinson R.G., Vordermeier H.M., Whelan A.O. Repeat tuberculin skin testing leads to desensitisation in naturally infected tuberculous cattle which is associated with elevated interleukin-10 and decreased interleukin-1 beta responses. Vet Res 2010, 41(2):p14.
18. Turk J.L. Relation between delayed hypersensitivity and cell-mediated immunity. J R Soc Med 1979, 72(4):243-245.
19. World Health Organisation Tuberculosis Research Office Certain characteristics of BCG-induced tuberculin sensitivity 1955, vol. 12. Bulletin of the World Health Organisation, p. 123-41.
20. Heimbeck J. Tuberculosis in hospital nurses. Tubercle 1936, 18:97-99.
21. Hart P.D., Sutherland I., Thomas J. The immunity conferred by effective BCG and whole bacillus vaccines in relation to individual variations in induced tuberculin sensitivity and to technical variations in the vaccines. Tubercle 1967, 48:201-210.
22. Comstock G.W. Identification of an effective vaccine against tuberculosis. Am Rev Respir Dis 1988, 138(2):479-480.
23. Fine P.E., Sterne J.A., Ponnighaus J.M., Rees R.J. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 1994, 344(8932):1245-1249.
24. Gallagher J., Horwill D.M. A selective oleic acid albumin agar medium for the cultivation of Mycobacterium bovis. J Hyg (Lond) 1977, 79(1):155-160.
25. Lyashchenko K., Whelan A.O., Greenwald R., Pollock J.M., Andersen P., Hewinson R.G., et al. Association of tuberculin-boosted antibody responses with pathology and cell-mediated immunity in cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovis. Infect Immun 2004, 72(5):2462-2467.
26. Wangoo A., Johnson L., Gough J., Ackbar R., Inglut D., Hicks D., et al. Advanced granulomatous lesions in Mycobacterium bovis-infected cattle are associated with increased expression of type I procollagen, gammadelta (WC1+) T cells and CD 68+ cells. J Comp Pathol 2005, 133(4):223-234.
27. Morrison W.I., Bourne F.J., Cox D.R., Donnelly C.A., Gettinby G., McInerney J.P., et al. Pathogenesis and diagnosis of infections with Mycobacterium bovis in cattle. Independent Scientific Group on Cattle TB. Vet Rec 2000, 146(9):236-242.
28. Dean G.S., Rhodes S.G., Coad M., Whelan A.O., Cockle P.J., Clifford D.J., et al. Minimum infective dose of Mycobacterium bovis in cattle. Infect Immun 2005, 73(10):6467-6471.
29. Horwitz O., Bunch-Christensen K. Correlation between tuberculin sensitivity after 2 months and 5 years among BCG vaccinated subjects. Bull World Health Organ 1972, 47(1):49-58.
30. Palmer C.E. BCG vaccination and tuberculin allergy. Lancet 1952, 1(6715):935-940.
31. Trial of BCG vaccines in south India for tuberculosis prevention. Indian J Med Res 1979, 70:349-363.
32. Floyd S., Ponnighaus J.M., Bliss L., Nkhosa P., Sichali L., Msiska G., et al. Kinetics of delayed-type hypersensitivity to tuberculin induced by bacille Calmette-Guerin vaccination in northern Malawi. J Infect Dis 2002, 186(6):807-814.
33. Griffin J.F., Mackintosh C.G., Slobbe L., Thomson A.J., Buchan G.S. Vaccine protocols to optimise the protective efficacy of BCG. Tuber Lung Dis 1999, 79(3):135-143.
34. Vordermeier H.M., Chambers M.A., Buddle B.M., Pollock J.M., Hewinson R.G. Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle. Vet J 2006, 171(2):229-244.
35. Ota M.O., Goetghebuer T., Vekemans J., Okoko B.J., Newport M.J., McAdam K.P., et al. Dissociation between tuberculin skin test and in vitro IFN-gamma responses following neonatal BCG vaccination. J Trop Pediatr 2006, 52(2):136-140.
36. Orme I.M., Collins F.M. Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cell Immunol 1984, 84(1):113-120.
37. Pais T.F., Silva R.A., Smedegaard B., Appelberg R., Andersen P. Analysis of T cells recruited during delayed-type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection. Immunology 1998, 95(1):69-75.